Antagonizing urotensin receptor is a novel therapeutic strategy for glucocorticoid‐induced skeletal muscle atrophy. Issue 5 (23rd May 2022)

Record Type:
Journal Article
Title:
Antagonizing urotensin receptor is a novel therapeutic strategy for glucocorticoid‐induced skeletal muscle atrophy. Issue 5 (23rd May 2022)
Main Title:
Antagonizing urotensin receptor is a novel therapeutic strategy for glucocorticoid‐induced skeletal muscle atrophy
Authors:
Yin, Lin
Li, Na
Jia, Weihua
Wang, Nuoqi
Liang, Meidai
Shang, Jiamin
Qiang, Guifen
Du, Guanhua
Yang, Xiuying
Abstract:
Is Part Of:
Clinical and translational medicine. Volume 12:Issue 5(2022)
Journal:
Clinical and translational medicine
Issue:
Volume 12:Issue 5(2022)
Issue Display:
Volume 12, Issue 5 (2022)
Year:
2022
Volume:
12
Issue:
5
Issue Sort Value:
2022-0012-0005-0000
Page Start:
n/a
Page End:
n/a
Publication Date:
2022-05-23
Subjects:
Clinical medicine -- Periodicals
Medicine, Experimental -- Periodicals
Medical innovations -- Periodicals
Molecular biology -- Periodicals
Pathology, Molecular -- Periodicals
616.027
Journal URLs:
https://onlinelibrary.wiley.com/loi/20011326 ↗
http://www.clintransmed.com/content ↗
http://www.biomedcentral.com/journals/#C ↗
http://www.springer.com/gb/ ↗
DOI:
10.1002/ctm2.879 ↗
Languages:
English
ISSNs:
2001-1326
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:
21738.xml